Cancer Trials in Caen, France
Conditions / Cancer / Caen, France
Research into Cancer spans multiple therapeutic approaches and trial phases.
46 total trials for this combination
Showing top 10 of 46 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01336634 | Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer. | COMPLETED | PHASE2 |
| NCT06533059 | A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors | RECRUITING | PHASE1 |
| NCT04410185 | Pain of Patients, Suffering of Caregivers: Evaluation of the Benefit of Full Consciousness Meditation in Oncology | COMPLETED | NA |
| NCT00082433 | Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer | COMPLETED | PHASE3 |
| NCT02668250 | Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality | COMPLETED | NA |
| NCT04459234 | Prospective Multicentre Study of the Use of Ketamine in the Treatment of Refractory Chronic Pain in the French CLCC | COMPLETED | — |
| NCT01235962 | A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) | COMPLETED | PHASE3 |
| NCT04397575 | The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients | COMPLETED | — |
| NCT04366154 | Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers | UNKNOWN | — |
| NCT00807859 | Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer | COMPLETED | PHASE1 |